<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40492559</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Reevaluating Preoperative Type and Screen: Identifying When It Is Necessary for Elective Colorectal Surgery.</ArticleTitle><Pagination><StartPage>1093</StartPage><EndPage>1099</EndPage><MedlinePgn>1093-1099</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003844</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Rising health care costs necessitate a reassessment of routine preoperative practices. Despite low transfusion rates in elective colorectal operations, many hospitals continue to perform routine preoperative type and screen testing.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess perioperative blood transfusion rates and determine preoperative and surgical factors associated with transfusions to determine whether the routine preoperative type and screen testing are necessary for elective abdominal colorectal surgeries, particularly in the setting of minimally invasive surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">Mayo Clinic, 2019-2023.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Adult patients undergoing elective abdominal colorectal operations. Exclusion criteria included emergent operations and nonabdominal procedures.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">None.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The primary outcome was the incidence of intraoperative and immediate postoperative (&#x2264;72 hours) blood product transfusion. Secondary outcomes assessed associations between transfusion rates, surgical approach, and preoperative variables.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 4652 patients, 2770 underwent minimally invasive surgery and 1882 underwent open procedures. Perioperative red blood cell transfusion rates were lower in minimally invasive procedures (3.0% colectomy, 4.5% proctectomy) compared to open procedures (8.7% colectomy, 21.5% proctectomy). Open proctectomy was the strongest predictor of transfusion (OR 12.05; 95% CI, 8.94-16.26; p &lt; 0.0001) followed by open colectomy (OR 2.59; 95% CI, 2.04-3.30; p &lt; 0.0001). Preoperative factors including ASA class IV (OR 5.21; 95% CI, 1.09-24.82; p &lt; 0.0382) and anemia (OR 4.14; 95% CI, 3.09-5.55; p &lt; 0.0001) were also significantly associated with red blood cell transfusion.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">The retrospective nature of the study may introduce selection bias. In addition, institutional practice patterns may limit the generalizability of findings.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients undergoing elective minimally invasive colorectal surgery have very low rates of perioperative blood transfusions; thus, routine preoperative type and screen testing is likely unnecessary for this patient cohort. However, patients undergoing planned open operations, likely due to procedural complexity, and those who are ASA class IV, have preoperative anemia, or have anal cancer have higher transfusion risks and may benefit from selective testing. Implementing a risk-stratified approach based on surgical technique and patient comorbidities could potentially reduce unnecessary testing and associated health care costs. See Video Abstract .</AbstractText><AbstractText Label="RETIPIFICACIN Y EVALUACIN PREOPERATORIAS CMO IDENTIFICAR CUNDO ES NECESARIA UNA CIRUGA COLORRECTAL ELECTIVA" NlmCategory="UNASSIGNED">ANTECEDENTES:El aumento en los costos de la atenci&#xf3;n m&#xe9;dica exigen la reevaluaci&#xf3;n de las practicas preoperatorias de rutina. A pesar de las bajas tasas de transfusi&#xf3;n en la cirug&#xed;a colorrectal electiva, muchos hospitales contin&#xfa;an realizando pruebas de tipo y de cribado preoperatorios de forma rutinaria. El poresente estudio eval&#xfa;a las tasas de transfusiones sangu&#xed;neas perioperatorias e identifica los factores asociados con &#xe9;stas transfusiones para determinar la necesidad de pruebas de tipo y de cribado preoperatorios de forma rutinaria en cirug&#xed;as colorrectales abdominales electivas.OBJETIVO:Evaluar las tasas de transfusi&#xf3;n sangu&#xed;nea perioperatoria y determinar los factores preoperatorios y quir&#xfa;rgicos asociados con las transfusiones, con el fin de determinar si las pruebas de tipo y de cribado preoperatorias de forma rutinaria son necesarias en cirug&#xed;as colorrectales abdominales electivas, en particular en el contexto de la cirug&#xed;a m&#xed;nimamente invasiva.DISE&#xd1;O:Estudio de cohortes retrospectivo.ESCENARIO:Cl&#xed;nica Mayo, 2019-2023.PACIENTES:Pacientes adultos sometidos a cirug&#xed;as colorrectales abdominales electivas. Los criterios de exclusi&#xf3;n incluyeron operaciones de emergencia y procedimientos no abdominales.INTERVENCIONES:Ninguna.PRINCIPALES MEDIDAS DE RESULTADOS:El resultado primario fue la incidencia de transfusi&#xf3;n de hemoderivados intraoperatoriamente y postoperatoria inmediata (&#x2264;72 horas). Los resultados secundarios evaluaron la asociaci&#xf3;n entre las tasas de transfusi&#xf3;n, el abordaje quir&#xfa;rgico y las variables preoperatorias.RESULTADOS:De 4652 pacientes, 2770 se sometieron a cirug&#xed;a m&#xed;nimamente invasiva y 1882 a laparotom&#xed;a. Las tasas de transfusi&#xf3;n eritrocitaria perioperatoria fueron menores en los procedimientos m&#xed;nimamente invasivos (3,0 % colectom&#xed;a, 4,5 % proctectom&#xed;a) que en los procedimientos abiertos (8,7 % colectom&#xed;a, 21,5 % proctectom&#xed;a). La proctectom&#xed;a abierta fue el predictor m&#xe1;s s&#xf3;lido de transfusi&#xf3;n (OR: 12,05; IC del 95 %: 8,94-16,26; p &lt; 0,0001), seguida de la colectom&#xed;a abierta (OR: 2,59; IC del 95 %: 2,04-3,30; p &lt; 0,0001). Los factores preoperatorios, incluyendo la clase ASA IV (OR 5,21; IC del 95 %: 1,09-24,82; p &lt; 0,0382) y la anemia (OR 4,14; IC del 95 %: 3,09-5,55; p &lt; 0,0001), tambi&#xe9;n se asociaron significativamente con la transfusi&#xf3;n de gl&#xf3;bulos rojos.LIMITACIONES:La naturaleza retrospectiva del estudio puede introducir sesgo de selecci&#xf3;n. Adem&#xe1;s, los patrones de pr&#xe1;ctica institucional pueden limitar la generalizaci&#xf3;n de los hallazgos.CONCLUSIONES:Los pacientes sometidos a cirug&#xed;a colorrectal m&#xed;nimamente invasiva electiva tienen tasas muy bajas de transfusiones sangu&#xed;neas perioperatorias, por lo que las pruebas de detecci&#xf3;n y tipo de sangre preoperatorias de rutina probablemente sean innecesarias para esta cohorte de pacientes. Sin embargo, los pacientes sometidos a cirug&#xed;as abiertas planificadas, probablemente debido a la complejidad del procedimiento, y aquellos con clase ASA IV, anemia preoperatoria o c&#xe1;ncer anal, tienen mayor riesgo de transfusi&#xf3;n y podr&#xed;an beneficiarse de pruebas selectivas. La implementaci&#xf3;n de un enfoque estratificado por riesgo basado en la t&#xe9;cnica quir&#xfa;rgica y las comorbilidades del paciente puede reducir las pruebas innecesarias y los costos de atenci&#xf3;n m&#xe9;dica asociados. (Traducci&#xf3;n-Dr. Xavier Delgadillo ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Sidrah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9545-1247</Identifier><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glasgow</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Robert D. and Patricia E. Kern Center for The Science of Health Care Delivery, Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajjar</LastName><ForeName>Roy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Ian S</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gleason</LastName><ForeName>Lauren T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Emilo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>William R G</ForeName><Initials>WRG</Initials><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathis</LastName><ForeName>Kellie L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKenna</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="Y">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="Y">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="Y">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003082" MajorTopicYN="Y">Colectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078542" MajorTopicYN="N">Proctectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019060" MajorTopicYN="N">Minimally Invasive Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood transfusion</Keyword><Keyword MajorTopicYN="N">Colorectal surgery</Keyword><Keyword MajorTopicYN="N">Health care cost reduction</Keyword><Keyword MajorTopicYN="N">Minimally invasive surgery</Keyword><Keyword MajorTopicYN="N">Preoperative testing</Keyword><Keyword MajorTopicYN="N">Type and screen</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>31</Day><Hour>20</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>10</Day><Hour>13</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>10</Day><Hour>7</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40492559</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003844</ArticleId><ArticleId IdType="pii">00003453-990000000-00969</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cavallaro P, Bordeianou L. Implementation of an ERAS pathway in colorectal surgery. Clin Colon Rectal Surg. 2019;32:102&#x2013;108.</Citation></Reference><Reference><Citation>Irani JL, Hedrick TL, Miller TE, et al. Clinical practice guidelines for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons and the Society of American Gastrointestinal and Endoscopic Surgeons. Dis Colon Rectum. 2023;66:15&#x2013;40.</Citation></Reference><Reference><Citation>Ozben V, Stocchi L, Ashburn J, Liu X, Gorgun E. Impact of a restrictive vs liberal transfusion strategy on anastomotic leakage and infectious complications after restorative surgery for rectal cancer. Colorectal Dis. 2017;19:772&#x2013;780.</Citation></Reference><Reference><Citation>Wu HL, Tai YH, Lin SP, Chan MY, Chen HH, Chang KY. The impact of blood transfusion on recurrence and mortality following colorectal cancer resection: a propensity score analysis of 4,030 patients. Sci Rep. 2018;8:13345.</Citation></Reference><Reference><Citation>Aquina CT, Blumberg N, Probst CP, et al. Large variation in blood transfusion use after colorectal resection: a call to action. Dis Colon Rectum. 2016;59:411&#x2013;418.</Citation></Reference><Reference><Citation>Booth AT, Allen S, Simianu VV, et al. Selective type &amp; screen for elective colectomy based on a transfusion risk score may generate substantial cost savings. Surg Endosc. 2022;36:8817&#x2013;8824.</Citation></Reference><Reference><Citation>Nanji S, Mir ZM, Karim S, et al. Perioperative blood transfusion and resection of colorectal cancer liver metastases: outcomes in routine clinical practice. HPB (Oxford). 2021;23:404&#x2013;412.</Citation></Reference><Reference><Citation>Tjaden A, Codispoti N, Yang LC, Pham T. Examining the utility and cost of routine type and screen prior to minimally invasive hysterectomy. JSLS. 2021;25:e2021.00020.</Citation></Reference><Reference><Citation>Fong ML, Urriza Rodriguez D, Elberm H, Berry DP. Are type and screen samples routinely necessary before laparoscopic cholecystectomy? J Gastrointest Surg. 2021;25:447&#x2013;451.</Citation></Reference><Reference><Citation>Abdelsattar ZM, Joshi V, Cassivi S, et al. Preoperative type and screen before general thoracic surgery: a nomogram to reduce unnecessary tests. Ann Thorac Surg. 2023;115:519&#x2013;525.</Citation></Reference><Reference><Citation>Ye SP, Qiu H, Liao SJ, Ai JH, Shi J. Mini-invasive vs open resection of colorectal cancer and liver metastases: a meta-analysis. World J Gastroenterol. 2019;25:2819&#x2013;2832.</Citation></Reference><Reference><Citation>McCullagh IJ, Begum S, Patel A, Gillies MA; UK Perioperative Medicine Clinical Trials Network Trial Development Group. Perioperative blood transfusion in major abdominal cancer surgery: a multi-centre service evaluation and national survey. BJA Open. 2022;3:100032.</Citation></Reference><Reference><Citation>Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg. 1992;216:633&#x2013;638.</Citation></Reference><Reference><Citation>Busch OR, Hop WC, van Papendrecht MAH, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med. 1993;328:1372&#x2013;1376.</Citation></Reference><Reference><Citation>Greenblatt DY, Rajamanickam V, Pugely AJ, Heise CP, Foley EF, Kennedy GD. Short-term outcomes after laparoscopic-assisted proctectomy for rectal cancer: results from the ACS NSQIP. J Am Coll Surg. 2011;212:844&#x2013;854.</Citation></Reference><Reference><Citation>McAlpine K, Forster AJ, Breau RH, et al. Robotic surgery improves transfusion rate and perioperative outcomes using a broad implementation process and multiple surgeon learning curves. Can Urol Assoc J. 2018;13:184&#x2013;189.</Citation></Reference><Reference><Citation>M&#xf6;rner ME, Edgren G, Martling A, Gunnarsson U, Egenvall M. Preoperative anaemia and perioperative red blood cell transfusion as prognostic factors for recurrence and mortality in colorectal cancer&#x2014;a Swedish cohort study. Int J Colorectal Dis. 2017;32:223&#x2013;232.</Citation></Reference><Reference><Citation>McKenna NP, Habermann EB, Glasgow AE, Cima RR. Tradition versus value: is there utility in protocolized postoperative laboratory testing after elective colorectal surgery? Ann Surg. 2021;274:e548&#x2013;e553.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40230551</PMID><DateRevised><Year>2025</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2754-4591</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>Suppl 2</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Oxford open digital health</Title><ISOAbbreviation>Oxf Open Digit Health</ISOAbbreviation></Journal><ArticleTitle>Understanding the impact of m<i>-</i>learning platform LEAP on learning outcomes and health care referral behavior of community health volunteers in Kenya.</ArticleTitle><Pagination><StartPage>ii25</StartPage><EndPage>ii31</EndPage><MedlinePgn>ii25-ii31</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/oodh/oqae036</ELocationID><Abstract><AbstractText Label="UNLABELLED">Mobile learning (m-learning) platforms are increasingly used to train healthcare workers as a strategy to address the global healthcare worker shortage. These platforms are also attractive because they are low-cost and accessible to anyone with a phone, providing the potential to foster equitable health information in the world's most remote and under-resourced areas. Because of this opportunity, many health initiatives have deployed m-learning approaches to meet their humanitarian goals, yet studies of their implementation are scattered. We provide a case study example of how a non-profit partnership between Amref and DataKind was leveraged to more robustly assess the data of the m-learning platform LEAP in Kenya, leading to a more in-depth understanding of its functionality and impact. These types of assessments are crucial to building data-informed decision making that can effectively advance the use of digital technologies for healthcare. The main findings from this work are as follows: (i) investment in analytics infrastructure is critical, (ii) structured m-learning programs have better outcomes, (iii) practicals are the most common activity, (iv) scores and completion rates are higher for learners that use the program in English and (v) referrals to health care facilities increased after formal LEAP programs.</AbstractText><AbstractText Label="RESUMEN" NlmCategory="RESULTS">Las plataformas de aprendizaje electr&#xf3;nico m&#xf3;vil (m-learning) est&#xe1;n siendo usadas con cada vez m&#xe1;s frecuencia en la capacitaci&#xf3;n de prestadores de salud, como una estrategia para enfrentar la escasez mundial de prestadores de salud. Estas plataformas son adem&#xe1;s atractivas por ser de bajo costo y f&#xe1;cil acceso para cualquier persona con un tel&#xe9;fono celular, haciendo posible una m&#xe1;s equitativa difusi&#xf3;n de la informaci&#xf3;n m&#xe9;dica, incluso en las zonas m&#xe1;s remotas y con menos recursos del mundo. Dadas estas oportunidades, muchas iniciativas sanitarias han desplegado planteamientos de aprendizaje m&#xf3;vil para alcanzar sus metas humanitarias, pero los estudios acerca de su implementaci&#xf3;n son algo dispersos. Presentamos aqu&#xed; un ejemplo de estudio de caso de c&#xf3;mo una colaboraci&#xf3;n sin fines de lucro entre Amref y DataKind fue apalancada financieramente para poder evaluar de manera m&#xe1;s robusta los datos de la plataforma de m-learning LEAP en Kenia, llevando a una comprensi&#xf3;n m&#xe1;s profunda de su funcionalidad e impacto. Este tipo de evaluaciones son cruciales para construir sistemas de toma de decisiones basadas en datos, que puedan avanzar de manera efectiva el uso de tecnolog&#xed;as digitales en el cuidado de la salud. Los hallazgos principales de este trabajo son: 1) la inversi&#xf3;n en infraestructura anal&#xed;tica es cr&#xed;tica, 2) los programas de m-learning estructurados tienen mejores resultados, 3) las pr&#xe1;cticas son la actividad m&#xe1;s com&#xfa;n, 4) las calificaciones y tasas de finalizaci&#xf3;n son mayores para los aprendices que usan el programa en ingl&#xe9;s, y 5) las referencias de pacientes a instalaciones de salud incrementaron tras el uso formal de los programas LEAP.</AbstractText><AbstractText Label="RESUMO" NlmCategory="UNASSIGNED">As plataformas de aprendizagem m&#xf3;vel (m-learning) s&#xe3;o cada vez mais utilizadas para formar profissionais de sa&#xfa;de como estrat&#xe9;gia para fazer face &#xe0; escassez global de profissionais de sa&#xfa;de. Estas plataformas s&#xe3;o tamb&#xe9;m atrativas por serem de baixo custo e acess&#xed;veis a qualquer pessoa com um telem&#xf3;vel, proporcionando o potencial para promover informa&#xe7;&#xe3;o de sa&#xfa;de equitativa nas &#xe1;reas mais remotas e com menos recursos do mundo. Devido a esta oportunidade, muitas iniciativas no dom&#xed;nio da sa&#xfa;de t&#xea;m utilizado abordagens de aprendizagem m&#xf3;vel para atingir os seus objetivos humanit&#xe1;rios, mas os estudos sobre a sua implementa&#xe7;&#xe3;o s&#xe3;o dispersos. Apresentamos um exemplo de estudo de caso de como uma parceria sem fins lucrativos entre a Amref e a DataKind foi aproveitada para avaliar de forma mais s&#xf3;lida os dados da plataforma de aprendizagem m&#xf3;vel LEAP no Qu&#xe9;nia, levando a uma compreens&#xe3;o mais aprofundada da sua funcionalidade e impacto. Estes tipos de avalia&#xe7;&#xf5;es s&#xe3;o cruciais para a tomada de decis&#xf5;es informadas por dados que possam efetivamente fazer avan&#xe7;ar a utiliza&#xe7;&#xe3;o das tecnologias digitais nos cuidados de sa&#xfa;de. As principais conclus&#xf5;es deste trabalho s&#xe3;o as seguintes: 1) o investimento em infraestruturas anal&#xed;ticas &#xe9; fundamental; 2) os programas estruturados de aprendizagem m&#xf3;vel t&#xea;m melhores resultados; 3) as atividades pr&#xe1;ticas s&#xe3;o as mais comuns; 4) as pontua&#xe7;&#xf5;es e as taxas de conclus&#xe3;o s&#xe3;o mais elevadas para os alunos que utilizam o programa em ingl&#xea;s; e 5) as refer&#xea;ncias a instala&#xe7;&#xf5;es de cuidados de sa&#xfa;de aumentaram ap&#xf3;s os programas formais LEAP.</AbstractText><AbstractText Label="R&#xc9;SUM&#xc9;" NlmCategory="UNASSIGNED">Les plateformes d'apprentissage mobile (m-learning) sont de plus en plus utilis&#xe9;es pour former les professionnels de la sant&#xe9; comme strat&#xe9;gie pour faire face &#xe0; la p&#xe9;nurie mondiale de personnels de sant&#xe9;. Ces plateformes sont &#xe9;galement attrayantes car elles sont peu co&#xfb;teuses et accessibles &#xe0; toute personne disposant d'un t&#xe9;l&#xe9;phone, offrant ainsi la possibilit&#xe9; de favoriser une information sanitaire &#xe9;quitable dans les zones les plus recul&#xe9;es et les moins dot&#xe9;es en ressources du monde. En raison de cette opportunit&#xe9;, de nombreuses initiatives en mati&#xe8;re de sant&#xe9; ont d&#xe9;ploy&#xe9; des approches d'apprentissage mobile pour atteindre leurs objectifs humanitaires, mais les &#xe9;tudes sur leur mise en &#x153;uvre sont dispers&#xe9;es. Nous fournissons un exemple d'&#xe9;tude de cas sur la mani&#xe8;re dont un partenariat &#xe0; but non lucratif entre Amref et DataKind a &#xe9;t&#xe9; exploit&#xe9; pour &#xe9;valuer de mani&#xe8;re plus fiable les donn&#xe9;es de la plateforme d'apprentissage mobile LEAP au Kenya, conduisant &#xe0; une compr&#xe9;hension plus approfondie de sa fonctionnalit&#xe9; et de son impact. Ces types d'&#xe9;valuations sont essentiels pour &#xe9;tablir une prise de d&#xe9;cision fond&#xe9;e sur des donn&#xe9;es qui peut faire progresser efficacement l'utilisation des technologies num&#xe9;riques dans les soins de sant&#xe9;. Les principales conclusions de ce travail sont les suivantes: 1) l'investissement dans les infrastructures d'analyse est essentiel, 2) les programmes d'apprentissage mobile structur&#xe9;s ont de meilleurs r&#xe9;sultats, 3) les travaux pratiques sont l'activit&#xe9; la plus courante, 4) les scores et les taux d'ach&#xe8;vement sont plus &#xe9;lev&#xe9;s pour les apprenants qui utilisent le programme en anglais, et 5) les r&#xe9;f&#xe9;rences aux &#xe9;tablissements de soins de sant&#xe9; ont augment&#xe9; apr&#xe8;s les programmes LEAP formels.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harnisher</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research, DataKind, New York City, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyubenko</LastName><ForeName>Anzhelika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Data Science, DataKind, Des Moines, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otieno</LastName><ForeName>Peter Kisare</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Health Innovations, Amref, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Oxf Open Digit Health</MedlineTA><NlmUniqueID>9918716088606676</NlmUniqueID><ISSNLinking>2754-4591</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Kenya</Keyword><Keyword MajorTopicYN="N">LEAP</Keyword><Keyword MajorTopicYN="N">community health volunteers</Keyword><Keyword MajorTopicYN="N">data science</Keyword><Keyword MajorTopicYN="N">m-learning</Keyword><Keyword MajorTopicYN="N">mobile health</Keyword></KeywordList><CoiStatement>The authors of this manuscript have declared no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>15</Day><Hour>4</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40230551</ArticleId><ArticleId IdType="pmc">PMC11936318</ArticleId><ArticleId IdType="doi">10.1093/oodh/oqae036</ArticleId><ArticleId IdType="pii">oqae036</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Collins TE, Akselrod S, Altymysheva Aet al. . The promise of digital health technologies for integrated care for maternal and child health and non-communicable diseases. BMJ (Clinical Research Ed) 2023;381:e071074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11778932</ArticleId><ArticleId IdType="pubmed">37220916</ArticleId></ArticleIdList></Reference><Reference><Citation>Krah EF, de Kruijf JG. Exploring the ambivalent evidence base of mobile health (mHealth): a systematic literature review on the use of mobile phones for the improvement of community health in Africa. Digital health 2016;2:2055207616679264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6001200</ArticleId><ArticleId IdType="pubmed">29942576</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Global Observatory for eHealth . mHealth: new horizons for health through mobile technologies: second global survey on eHealth. World Health Organization
2011;3:1&#x2013;99. https://iris.who.int/handle/10665/44607</Citation></Reference><Reference><Citation>Winters N, Langer L, Nduku Pet al. . Using mobile technologies to support the training of community health workers in low-income and middle-income countries: mapping the evidence. BMJ Glob Health 2019;4:e001421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6673767</ArticleId><ArticleId IdType="pubmed">31413872</ArticleId></ArticleIdList></Reference><Reference><Citation>Boniol M, Kunjumen T, Nair TSet al. . The global health workforce stock and distribution in 2020 and 2030: a threat to equity and &#x201c;universal&#x201d; health coverage? BMJ Glob Health 2022;7:e009316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9237893</ArticleId><ArticleId IdType="pubmed">35760437</ArticleId></ArticleIdList></Reference><Reference><Citation>Early J, Gonzalez C, Gordon-Dseagu Vet al. . Use of mobile health (mHealth) technologies and interventions among community health workers globally: a scoping review. Health Promot Pract 2019;20:805&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">31179777</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) . (2020).
Digital education for building health workforce capacity. Geneva: World Health Organization. https://apps.who.int/iris/bitstream/handle/10665/331524/9789240000476-eng.pdf</Citation></Reference><Reference><Citation>Muyinda PB, Mugisa E, Lynch K. M-learning: the educational use of mobile communication devices. Strengthening the Role of ICT in Development 2007;72:290&#x2013;301.</Citation></Reference><Reference><Citation>Crompton H. A historical overview of m-learning: Toward learner-centered education. In: Handbook of mobile learning. New York, London: Routledge, 2013, 3&#x2013;14.</Citation></Reference><Reference><Citation>Criollo-C S, Guerrero-Arias A, Jaramillo-Alc&#xe1;zar &#xc1;et al. . Mobile learning technologies for education: benefits and pending issues. Appl Sci 2021;11:4111.</Citation></Reference><Reference><Citation>Mc Kenna P, Babughirana G, Amponsah Met al. . Mobile training and support (MOTS) service&#x2014;using technology to increase Ebola preparedness of remotely-located community health workers (CHWs) in Sierra Leone. mHealth 2019;5:35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6789201</ArticleId><ArticleId IdType="pubmed">31620462</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulley AM. Investigating the use of m-health for learning and clinical training by medical students in Ghana. Electronic Thesis and Dissertation Repository
2018;5970. https://ir.lib.uwo.ca/etd/5970</Citation></Reference><Reference><Citation>Dankasa J. Examining the progression of mobile technologies and their applications to learning environment: implications for m-learning in Africa. International Journal of Research Studies in Educational Technology 2014;3:7&#x2013;8.</Citation></Reference><Reference><Citation>History . (n.d.). Amref Canada .
Retrieved from
https://amrefcanada.org/history/</Citation></Reference><Reference><Citation>LEAP . Our Solution, 2021. https://leaphealthmobile.com/our-solution/</Citation></Reference><Reference><Citation>Masaba BB, Moturi JK, Taiswa Jet al. . Devolution of healthcare system in Kenya: progress and challenges. Public Health 2020;189:135&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">33227596</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatotoh AM. Learner characteristics, behaviour, technology use and adoption of mobile learning among community health care trainees, Amref Health Africa, Kenya (Doctoral dissertation. Nairobi, Kenya: University of Nairobi; ), 2017.</Citation></Reference><Reference><Citation>UN . World Population Prospects 2022. Department of Economic and Social Affairs - Population Division. New York: United Nation, 2022. https://population.un.org/wpp/Download/Standard/Population/</Citation></Reference><Reference><Citation>Addisalem, Y.
Here Are The Countries Where Swahili Is Spoken. The Mezzofanti Guild: Mezzoguild, 2014. Retrieved from
https://www.mezzoguild.com/swahili-countries/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40163827</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1853-0605</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Mar</Month><Day>31</Day></PubDate></JournalIssue><Title>Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)</Title><ISOAbbreviation>Rev Fac Cien Med Univ Nac Cordoba</ISOAbbreviation></Journal><ArticleTitle>[Residual hypoxemia during titration with self-adjusting CPAP at home in patients without prior adaptation].</ArticleTitle><Pagination><StartPage>61</StartPage><EndPage>77</EndPage><MedlinePgn>61-77</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.31053/1853.0605.v82.n1.44671</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Self-adjusting titration (APAP) at home is accepted to define therapeutic pressure (CPAPT). The APAP device report may be insufficient to ensure adequate therapeutic response in all patients. There is no consensus on the use of oximetry during APAP titration.</AbstractText><AbstractText Label="OBJECTIVE">To evaluate the prevalence and magnitude of residual hypoxemia (RH) in titration with APAP not monitored at home and to identify related variables.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Retrospective study based on APAP titrations with coupled oximetry, arterial blood gases and spirometry test. A T90 &gt; 10% of the night was considered significant RH. Predictors of HR were identified by logistic regression (RL).</AbstractText><AbstractText Label="RESULTS">116 cases were included. 41% in the group with RH. These were older (66.7 vs. 59.6 years, p: 0.02), lower absolute FEV1 (2.17 vs. 2.57 liters, p: 0.06), lower absolute FVC (2.9 vs. 3.3 liters, p: 0.02) and lower basal PO2 (77.3 vs. 84.2 mmHg, p: 0.04). The titration period reached 3.6 &#xb1; 1 nights, average adherence of 374 &#xb1; 88.4 minutes/night; CPAPT (cm H2O): 9.4 &#xb1; 1.8, AHIr; 3.1 &#xb1; 3.2 ev/h and leaks (liters/min): 19.7 &#xb1; 11.2. Multiple logistic regression identified age &gt; 66 years as a predictor of RH (OR 3.32, 95% CI 1.43 - 7.69, p: 0.005) and FEV1 &lt; 1.76 liters (OR 3.29 &#x2013; IC95% 1.27 &#x2013; 8.53, p: 0.0139).</AbstractText><AbstractText Label="CONCLUSIONS">Incompletely corrected nocturnal oximetry was observed in a significant proportion of patients with APAP. Age over 66 years and absolute FEV1 &lt; 1.76 liters were correlated with residual hypoxemia.</AbstractText><CopyrightInformation>Universidad Nacional de C&#xf3;rdoba</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Franzoy</LastName><ForeName>Julieta</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Brit&#xe1;nico de Buenos Aires.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanco</LastName><ForeName>Magali</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Brit&#xe1;nico de Buenos Aires.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ernst</LastName><ForeName>Glenda</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital Brit&#xe1;nico de Buenos Aires.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ginetti</LastName><ForeName>Maria Belen</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Hospital Brit&#xe1;nico de Buenos Aires.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perri</LastName><ForeName>Marcella</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Brit&#xe1;nico de Buenos Aires.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borsini</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Brit&#xe1;nico de Buenos Aires.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Hipoxemia residual durante la titulaci&#xf3;n con CPAP autoajustable en domicilio en pacientes sin adaptaci&#xf3;n previa.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Argentina</Country><MedlineTA>Rev Fac Cien Med Univ Nac Cordoba</MedlineTA><NlmUniqueID>8303003</NlmUniqueID><ISSNLinking>0014-6722</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="Y">Hypoxia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010092" MajorTopicYN="N">Oximetry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045422" MajorTopicYN="Y">Continuous Positive Airway Pressure</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020181" MajorTopicYN="Y">Sleep Apnea, Obstructive</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013147" MajorTopicYN="N">Spirometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001784" MajorTopicYN="N">Blood Gas Analysis</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="INTRODUCCI&#xd3;N">La titulaci&#xf3;n autoajustable (APAP) en domicilio es aceptada para definir presi&#xf3;n terap&#xe9;utica (CPAPT). La informaci&#xf3;n obtenida desde el APAP puede ser insuficiente para asegurar adecuada respuesta terap&#xe9;utica en todos los pacientes. No existe consenso sobre el uso de oximetr&#xed;a durante la titulaci&#xf3;n con APAP.</AbstractText><AbstractText Label="OBJETIVO">Evaluar prevalencia y magnitud de la hipoxemia residual (HR) en la titulaci&#xf3;n con APAP no vigilada en domicilio e identificar variables relacionadas.</AbstractText><AbstractText Label="MATERIALES Y M&#xc9;TODOS">Estudio retrospectivo basado en titulaciones de APAP con oximetr&#xed;a acoplada, gases en sangre arterial y espirometr&#xed;a. Un T90 &gt; de 10% de la noche se consider&#xf3; HR significativa. Se identificaron predictores de HR por regresi&#xf3;n log&#xed;stica (RL) Resultados: Incluimos 116 casos. 41% pertenecieron al grupo con HR. Estos tuvieron mayor edad (66.7 vs. 59.6 a&#xf1;os, p: 0.02), menor VEF1 absoluto (2.17 vs. 2.57 litros, p: 0.06), menor CVF absoluta (2.9 vs. 3.3 litros, p: 0.02) y menor PO2 basal (77.3 vs. 84.2 mmHg, p: 0.04). El periodo de titulaci&#xf3;n alcanz&#xf3; 3.6 &#xb1; 1 noches, adherencia media de 374 &#xb1; 88.4 minutos/noche; CPAPT (cm H2O): 9.4 &#xb1; 1.8, IAHr; 3.1 &#xb1; 3.2 ev/h y fugas (litros/min): 19.7 &#xb1; 11.2. Fueron predictores de HR; edad &gt; 66 a&#xf1;os (OR 3.32, IC95% 1.43 - 7.69, p: 0.005) y el VEF1 &lt; 1.76 litros (OR 3.29 - IC95% 1.27 - 8.53, p: 0.0139).</AbstractText><AbstractText Label="CONCLUSIONES">Una significativa proporci&#xf3;n de pacientes que titulan con APAP corrigen incompletamente la oximetr&#xed;a nocturna. La edad &gt; 66 a&#xf1;os y el VEF1 absoluto &lt; 1.76 litros se correlacionaron con hipoxemia residual.</AbstractText><CopyrightInformation>Universidad Nacional de C&#xf3;rdoba</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">sleep apnea obstructive</Keyword><Keyword MajorTopicYN="N">hypoxia</Keyword><Keyword MajorTopicYN="N">continuous positive airway pressure</Keyword></KeywordList><CoiStatement>
<b>Conflicto de inter&#xe9;s</b>
. 
Ninguno.
Limitaciones de responsabilidad
La responsabilidad de esta publicaci&#xf3;n es de los autores.
Fuentes de apoyo
No posee.
Originalidad
Este art&#xed;culo es original y no ha sido enviado para su publicaci&#xf3;n a otro medio de difusi&#xf3;n cient&#xed;fica en forma completa ni parcialmente.
Cesi&#xf3;n de derechos
Quienes participaron en la elaboraci&#xf3;n de este art&#xed;culo, ceden los derechos de autor a la Universidad Nacional de C&#xf3;rdoba para publicar en la Revista de la Facultad de Ciencias M&#xe9;dicas de C&#xf3;rdoba y realizar las traducciones necesarias al idioma ingl&#xe9;s.
Contribuci&#xf3;n de los autores
Quienes participaron en la elaboraci&#xf3;n de este art&#xed;culo, han trabajado en la concepci&#xf3;n del dise&#xf1;o, recolecci&#xf3;n de la informaci&#xf3;n y elaboraci&#xf3;n del manuscrito, haci&#xe9;ndose p&#xfa;blicamente responsables de su contenido y aprobando su versi&#xf3;n final.
</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>31</Day><Hour>21</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>31</Day><Hour>21</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>31</Day><Hour>16</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40163827</ArticleId><ArticleId IdType="pmc">PMC12057706</ArticleId><ArticleId IdType="doi">10.31053/1853.0605.v82.n1.44671</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nogueira F, Nigro C, Cambursano H, Borsini E, Silio J, Avila J. Gu&#xed;as pr&#xe1;cticas de diagn&#xf3;stico y tratamiento del s&#xed;ndrome de apneas e hipopneas obstructivas del sue&#xf1;o [Practical guidelines for the diagnosis and treatment of obstructive sleep apnea syndrome] Medicina (B Aires) 2013;73(4):349&#x2013;62. Spanish.</Citation><ArticleIdList><ArticleId IdType="pubmed">23924537</ArticleId></ArticleIdList></Reference><Reference><Citation>Mediano O, Gonz&#xe1;lez Mangado N, Montserrat JM, Alonso-&#xc1;lvarez ML, Almendros Alonso- Fern&#xe1;ndez A, Barb&#xe9; F, Borsini E, Caballero- Eraso C, Cano- Pumarega I, de Carlos Villafranca F, Carmona-Bernal C, Carrillo Alduenda JL, Chiner E, Cordero Guevara JA, de Manuel L, Dur&#xe1;n-Cantolla J, Farr&#xe9; R, Franceschini C, Gaig C, Garcia Ramos P, Garc&#xed;a- R&#xed;o F, Garmendia O, G&#xf3;mez Garc&#xed;a T, Gonz&#xe1;lez Pondal S, Hoyo Rodrigo MB, Lecube A, Madrid JA, Maniegas Lozano L, Mart&#xed;nez Carrasco JL, Masa JF, Masdeu Margalef MJ, Mayos P&#xe9;rez M, Mirabet Lis E, Monasterio C, Navarro Soriano N, Olea de la Fuente E, Plaza G, Puertas Cuesta FJ, Rabec C, Resano P, Rigau D, Roncero A, Ruiz C, Salord N, Saltijeral A, Sampol Rubio G, S&#xe1;nchez Quiroga M&#xc1;, Sans Capdevila &#xd3;, Teixeira C, Tinahones Madue&#xf1;o F, Maria Togeiro S, Troncoso Acevedo MF, Vargas Ram&#xed;rez LK, Winck J, Zabala Urionaguena N, Egea C, el Spanish Sleep Network International Consensus Document on Obstructive Sleep Apnea. Arch Bronconeumol. 2022 Jan;58(1):52&#x2013;68. doi: 10.1016/j.arbres.2021.03.017. English, Spanish.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arbres.2021.03.017</ArticleId><ArticleId IdType="pubmed">33875282</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgenthaler TI, Aurora RN, Brown T, Zak R, Alessi C, Boehlecke B, Chesson AL Jr, Friedman L, Kapur V, Maganti R, Owens J, Pancer J, Swick TJ, Standards of Practice Committee of the AASM. American Academy of Sleep Medicine Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007. An American Academy of Sleep Medicine report . Sleep. 2008 Jan;31(1):141&#x2013;7. doi: 10.1093/sleep/31.1.141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/31.1.141</ArticleId><ArticleId IdType="pmc">PMC2225554</ArticleId><ArticleId IdType="pubmed">18220088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebben MR, Narizhnaya M, Krieger AC. A new predictive model for continuous positive airway pressure in the treatment of obstructive sleep apnea. Sleep Breath. 2017 May;21(2):4</Citation><ArticleIdList><ArticleId IdType="pubmed">27878543</ArticleId></ArticleIdList></Reference><Reference><Citation>Monasterio C, Mayos M, Ter&#xe1;n J, Hern&#xe1;ndez L, Barb&#xe9; F, Maim&#xf3; A, Rubio M, Montserrat JM. Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am J Respir Crit Care Med. 2004 Dec 1;170(11):1218&#x2013;24. doi: 10.1164/rccm.200312-1787OC.35-442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200312-1787OC.35-442</ArticleId><ArticleId IdType="pubmed">15282204</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco M, Ernst G, Salvado A, Borsini E. Impact of Mask Type on the Effectiveness of and Adherence to Unattended Home-Based CPAP Titration. Sleep Disord. 2019 Mar 25;2019:4592462. doi: 10.1155/2019/4592462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/4592462</ArticleId><ArticleId IdType="pmc">PMC6452566</ArticleId><ArticleId IdType="pubmed">31019811</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco M, Ernst G, Valiensi S, Berrozpe E, Mart&#xed;nez O, Borsini E. Eficiencia del sue&#xf1;o en la polisomnograf&#xed;a nivel II de pacientes ambulatorios y hospitalizados [Sleep efficiency in level II polysomnography of hospitalized and outpatients] Medicina (B Aires) 2020;80(4):317&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">32841134</ArticleId></ArticleIdList></Reference><Reference><Citation>Frange C, Franco AM, Brasil E, Hirata RP, Lino JA, Mortari DM, Ykeda DS, Leoc&#xe1;dio Miguel MA, D'Aurea CVR, Silva LOE, Telles SCL, Furlan SF, Peruchi BB, Leite CF, Yagihara FT, Campos LD, Ulh&#xf4;a MA, Cruz MGDR, Beidacki R, Santos RB, de Queiroz SS, Barreto S, Piccin VS, Coelho FMS, Studart L, Assis M, Drager LF. Practice recommendations for the role of physiotherapy in the management of sleep disorders: the 2022 Brazilian Sleep Association Guidelines. Sleep Sci. 2022 Oct-Dec;15(4):515&#x2013;573. doi: 10.5935/1984-0063.20220083.</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/1984-0063.20220083</ArticleId><ArticleId IdType="pmc">PMC9670776</ArticleId><ArticleId IdType="pubmed">36419815</ArticleId></ArticleIdList></Reference><Reference><Citation>Blekic N, Bold I, Mettay T, Bruyneel M. Impact of Desaturation Patterns versus Apnea- Hypopnea Index in the Development of Cardiovascular Comorbidities in Obstructive Sleep Apnea Patients. Nat Sci Sleep. 2022 Aug 25;14:1457&#x2013;1468. doi: 10.2147/NSS.S374572.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NSS.S374572</ArticleId><ArticleId IdType="pmc">PMC9423119</ArticleId><ArticleId IdType="pubmed">36045914</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco M, Ernst G, Salvado A, Borsini E. Impact of Mask Type on the Effectiveness of and Adherence to Unattended Home-Based CPAP Titration. Sleep Disord. 2019 Mar 25;2019:4592462. doi: 10.1155/2019/4592462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/4592462</ArticleId><ArticleId IdType="pmc">PMC6452566</ArticleId><ArticleId IdType="pubmed">31019811</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsini E, Blanco M. La edad y el uso de m&#xe1;scara oronasal se asocian con menor calidad en la titulaci&#xf3;n con CPAP autoajustable en domicilio en pacientes sin adaptaci&#xf3;n. Respirar. 2023;15(2) https://respirar.alatorax.org/index.php/respirar/article/view/157</Citation></Reference><Reference><Citation>Banerjee D, Yee BJ, Piper AJ, Zwillich CW, Grunstein RR. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest. 2007 Jun;131(6):1678&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">17565018</ArticleId></ArticleIdList></Reference><Reference><Citation>McNicholas WT. COPD-OSA Overlap Syndrome: Evolving Evidence Regarding Epidemiology, Clinical Consequences, and Management. Chest. 2017 Dec;152(6):1318&#x2013;1326. doi: 10.1378/chest.06-2447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.06-2447</ArticleId><ArticleId IdType="pubmed">28442310</ArticleId></ArticleIdList></Reference><Reference><Citation>Kar S. Cardiovascular implications of obstructive sleep apnea associated with the presence of a patent foramen ovale. Sleep Med Rev. 2014 Oct;18(5):399&#x2013;404. doi: 10.1016/j.smrv.2014.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2014.02.002</ArticleId><ArticleId IdType="pubmed">24703203</ArticleId></ArticleIdList></Reference><Reference><Citation>Koivum&#xe4;ki V, Maasilta P, Bachour A. Oximetry Monitoring Recommended During PAP Initiation for Sleep Apnea in Patients With Obesity or Nocturnal Hypoxemia. J Clin Sleep Med. 2018 Nov 15;14(11):1859&#x2013;1863. doi: 10.5664/jcsm.7480.</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.7480</ArticleId><ArticleId IdType="pmc">PMC6223566</ArticleId><ArticleId IdType="pubmed">30373690</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd SB, Upender R, Walters AS, Goodpaster RL, Stanley JJ, Wang L, Chandrasekhar R. Effective Apnea- Hypopnea Index ("Effective AHI"): A New Measure of Effectiveness for Positive Airway Pressure Therapy. Sleep. 2016 Nov 1;39(11):1961&#x2013;1972. doi: 10.5665/sleep.6224.</Citation><ArticleIdList><ArticleId IdType="doi">10.5665/sleep.6224</ArticleId><ArticleId IdType="pmc">PMC5070750</ArticleId><ArticleId IdType="pubmed">27568799</ArticleId></ArticleIdList></Reference><Reference><Citation>Culpepper DJ, Hong D, Ryden A, Currier J, Tobis JM, De Cruz S, Zeidler MR. A 38- Year- Old Man With Well Treated OSA on CPAP With Persistent Nocturnal Hypoxemia. Chest. 2020 Jan;157(1):e1&#x2013;e3. doi: 10.1016/j.chest.2019.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2019.06.045</ArticleId><ArticleId IdType="pubmed">31916968</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee D, Yee BJ, Piper AJ, Zwillich CW, Grunstein RR. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest. 2007 Jun;131(6):1678&#x2013;84. doi: 10.1378/chest.06-2447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.06-2447</ArticleId><ArticleId IdType="pubmed">17565018</ArticleId></ArticleIdList></Reference><Reference><Citation>Koivum&#xe4;ki V, Maasilta P, Bachour A. Oximetry Monitoring Recommended During PAP Initiation for Sleep Apnea in Patients With Obesity or Nocturnal Hypoxemia. J Clin Sleep Med. 2018 Nov 15;14(11):1859&#x2013;1863. doi: 10.5664/jcsm.7480.</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.7480</ArticleId><ArticleId IdType="pmc">PMC6223566</ArticleId><ArticleId IdType="pubmed">30373690</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39801613</PMID><DateRevised><Year>2025</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1758-8340</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Therapeutic advances in medical oncology</Title><ISOAbbreviation>Ther Adv Med Oncol</ISOAbbreviation></Journal><ArticleTitle>Enhancing rare cancer care in developing countries through patient advocacy: insights from the Desmoid Tumor Brazilian Association.</ArticleTitle><Pagination><StartPage>17588359241309827</StartPage><MedlinePgn>17588359241309827</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17588359241309827</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/17588359241309827</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Desmoid tumors are soft-tissue neoplasms that can have profound impacts on the lives of people living with such diseases. As they are rare tumors, patients often have difficulty finding teams specialized in sarcomas and support networks. In low- and middle-income countries, the challenges are exacerbated due to a need for established networks and medication access.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">In this setting, patient advocacy groups are important in supporting affected people. To this end, the Desmoid Tumor Brazilian Association (DTBA) was established to help mitigate those challenges. This paper highlights the perspectives of patients with desmoid tumors living in Brazil, obtained in a nationwide survey, and discusses aspects related to access to specialists, medications, education, and awareness in Brazil.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The most commonly reported challenges in Brazil are access to educational material and specialists. The DTA continues to strive to improve support for people living in Brazil through initiatives such as Scientific and Educational Meetings, improving awareness, fostering science, and working on methods to facilitate access to medication and specialists.</AbstractText><CopyrightInformation>&#xa9; The Author(s), 2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Philippos Apolinario</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0001-9681-0515</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Division of Oncology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menezes</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Desmoid Tumor Brazilian Association, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bianca Lopes David</LastName><ForeName>Bruna</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio De Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grupo Oncoclinicas, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Georgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Desmoid Tumor Brazilian Association, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prudente Barbieri</LastName><ForeName>Livia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1547-5108</Identifier><AffiliationInfo><Affiliation>Desmoid Tumor Brazilian Association, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7771-8059</Identifier><AffiliationInfo><Affiliation>Department of Medical Oncology, Sarcoma and Bone Tumors Reference Center, A.C. Camargo Cancer Center, R. Prof. Ant&#xf4;nio Prudente, 211, S&#xe3;o Paulo, SP 01509-010, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ther Adv Med Oncol</MedlineTA><NlmUniqueID>101510808</NlmUniqueID><ISSNLinking>1758-8340</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>How patient advocacy groups can improve care for rare diseases: perspectives from a Desmoid Tumor Patient Group in a developing country Desmoid tumors are rare tumors that can have profound impacts on the lives of people living with such diseases, as they can invade surrounding structures, leading to deformities and pain. Managing these tumors can be challenging, as treatments often have strong side effects, and finding doctors or support groups with expertise in this condition is difficult. In low- and middle-income countries like Brazil, those difficulties are even higher due to limited access to specialists and medications. To address these issues, the Desmoid Tumor Brazilian Association (DTBA) was created, providing support to patients and their families, raising awareness, and improving education about this rare disease. This article gives the perspective of the DTBA, explores the experiences of people in Brazil living with desmoid tumors, and examines the challenges they face in accessing care, treatments, and reliable information. Resumo Leigo Os tumores desmoides s&#xe3;o tumores raros que podem ter impactos profundos na vida das pessoas que convivem com essa doen&#xe7;a, pois podem invadir estruturas ao redor, causando deformidades e dor. O manejo desses tumores pode ser desafiador, j&#xe1; que os tratamentos frequentemente apresentam efeitos colaterais fortes, e encontrar m&#xe9;dicos ou grupos de apoio especializados nessa condi&#xe7;&#xe3;o &#xe9; dif&#xed;cil. Em pa&#xed;ses de baixa e m&#xe9;dia renda, como o Brasil, essas dificuldades s&#xe3;o ainda maiores devido ao acesso limitado a especialistas e medicamentos. Para enfrentar esses desafios, foi criada a Associa&#xe7;&#xe3;o Brasileira de Tumor Desmoide (ABTD), que oferece suporte a pacientes e suas fam&#xed;lias, promove conscientiza&#xe7;&#xe3;o e melhora a educa&#xe7;&#xe3;o sobre essa doen&#xe7;a rara. Este artigo apresenta a perspectiva da ABTD, explora as experi&#xea;ncias das pessoas que vivem com tumores desmoides no Brasil e analisa os desafios que enfrentam para acessar cuidados, tratamentos e informa&#xe7;&#xf5;es confi&#xe1;veis. Resumen en Lenguaje Sencillo Los tumores desmoides son tumores poco comunes que pueden tener un impacto profundo en la vida de las personas que padecen esta enfermedad, ya que pueden invadir estructuras circundantes, provocando deformidades y dolor. Tratar estos tumores puede ser un desaf&#xed;o, ya que los tratamientos suelen tener efectos secundarios intensos, y encontrar m&#xe9;dicos o grupos de apoyo especializados en esta condici&#xf3;n es dif&#xed;cil. En pa&#xed;ses de ingresos bajos y medios, como Brasil, estas dificultades son a&#xfa;n mayores debido al acceso limitado a especialistas y medicamentos. Para abordar estos desaf&#xed;os, se cre&#xf3; la Asociaci&#xf3;n Brasile&#xf1;a de Tumor Desmoide (ABTD), que brinda apoyo a pacientes y sus familias, promueve la concienciaci&#xf3;n y mejora la educaci&#xf3;n sobre esta enfermedad rara. Este art&#xed;culo presenta la perspectiva de la ABTD, explora las experiencias de las personas que viven con tumores desmoides en Brasil y analiza los desaf&#xed;os que enfrentan para acceder a la atenci&#xf3;n m&#xe9;dica, los tratamientos y la informaci&#xf3;n confiable.</AbstractText><CopyrightInformation>&#xa9; The Author(s), 2025.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brazil</Keyword><Keyword MajorTopicYN="N">aggressive fibromatosis</Keyword><Keyword MajorTopicYN="N">desmoid tumor</Keyword><Keyword MajorTopicYN="N">low or middle-income countries</Keyword><Keyword MajorTopicYN="N">patient advocacy</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>13</Day><Hour>5</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39801613</ArticleId><ArticleId IdType="pmc">PMC11719451</ArticleId><ArticleId IdType="doi">10.1177/17588359241309827</ArticleId><ArticleId IdType="pii">10.1177_17588359241309827</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Costa PA, Marbin S, Costa B, et al.. A nonrandom association of breast implants and the formation of desmoid tumors. Breast J 2021; 27(10): 768&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pubmed">34453383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper B, Baldini EH, Bonvalot S, et al.. Current management of desmoid tumors: a review. JAMA Oncol 2024; 10(8): 1121.</Citation><ArticleIdList><ArticleId IdType="pubmed">38900421</ArticleId></ArticleIdList></Reference><Reference><Citation>Weis J. Support groups for cancer patients. Support Care Cancer 2003; 11(12): 763&#x2013;768.</Citation><ArticleIdList><ArticleId IdType="pubmed">14564493</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper B, Gounder M, Hernandez L, et al.. Capturing patient voice to improve outcomes that matter to patients with desmoid tumor. Cancer Manag Res 2024; 16: 617&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11166168</ArticleId><ArticleId IdType="pubmed">38863992</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva C, Pinto FFE, Lopes A, et al.. Clinical and epidemiologic evaluation of desmoid tumors in a Brazilian Sarcoma Reference Center. Acta Ortop Bras 2024; 32(2): e274225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11197944</ArticleId><ArticleId IdType="pubmed">38933357</ArticleId></ArticleIdList></Reference><Reference><Citation>Tansir G, Sharma A, Biswas B, et al.. A real-world study on the clinicopathological profile, treatment outcomes and health-related quality of life, anxiety and depression among patients with desmoid tumor at two tertiary care centers in India. Front Oncol 2024; 14: 1382856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11532177</ArticleId><ArticleId IdType="pubmed">39497712</ArticleId></ArticleIdList></Reference><Reference><Citation>David BBL, Abdon Mello C, Santos Thuler LC, et al.. Overview of adult sarcoma burden and clinical pathways in Brazil. JCO Glob Oncol 2022; 8: e2100387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8887943</ArticleId><ArticleId IdType="pubmed">35230876</ArticleId></ArticleIdList></Reference><Reference><Citation>Zumarraga JP, Coimbra B, Dos Santos FG, et al.. Extra-abdominal desmoid tumor: analysis of 23 consecutive cases in a Single Institution. Acta Ortop Bras 2018; 26(4): 244&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6131287</ArticleId><ArticleId IdType="pubmed">30210253</ArticleId></ArticleIdList></Reference><Reference><Citation>Improta L, Tzanis D, Bouhadiba T, et al.. Desmoid tumours in the surveillance era: what are the remaining indications for surgery? Eur J Surg Oncol 2020; 46(7): 1310&#x2013;1314.</Citation><ArticleIdList><ArticleId IdType="pubmed">32340818</ArticleId></ArticleIdList></Reference><Reference><Citation>Desmoid Tumor Working Group. The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer 2020; 127: 96&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">32004793</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos NRD. SUS, pol&#xed;tica p&#xfa;blica de Estado: seu desenvolvimento institu&#xed;do e instituinte e a busca de sa&#xed;das. Ci&#xea;nc sa&#xfa;de coletiva 2013; 18(1): 273&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">23338517</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainstock D, Katz A. Advancing rare disease policy in Latin America: a call to action. Lancet Reg Health Am 2023; 18: 100434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9950655</ArticleId><ArticleId IdType="pubmed">36844013</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamlin J, Gibbon S, Sesia PM, et al.. Judicialisation and the politics of rare disease in Brazil: Rethinking activism and inequalities. In: Gibbon S, Sesia PM, Berr&#xed;o L, et al.. (eds) Critical medical anthropology: Perspectives in and from Latin America, 2020, pp. 248&#x2013;269.</Citation></Reference><Reference><Citation>Alcindor T, Dumitra S, Albritton K, et al.. Disparities in cancer care: the example of sarcoma-in search of solutions for a global issue. Am Soc Clin Oncol Educ Book 2021; 41: 1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33770458</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatta G, van der Zwan JM, Casali PG, et al.. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer 2011; 47(17): 2493&#x2013;2511.</Citation><ArticleIdList><ArticleId IdType="pubmed">22033323</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloomberg New Economy International Cancer Coalition, McKinsey Cancer Center and Cure 4 Cancer. Advancing global health equity in oncology clinical trial access. Cancer Discov 2024; 14(12): 2317&#x2013;2323.</Citation><ArticleIdList><ArticleId IdType="pubmed">39315831</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiller CA, Trama A, Serraino D, et al.. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer 2013; 49(3): 684&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pubmed">23079473</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmagnani Pestana R. Strategies for equality in cancer care in low- and middle-income countries. JAMA Netw Open 2024; 7(4): e244949.</Citation><ArticleIdList><ArticleId IdType="pubmed">38568696</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva RE, Amato AA, Guilhem DB, et al.. International Clinical Trials in Latin American and Caribbean Countries: research and development to meet local health needs. Front Pharmacol 2017; 8: 961.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5760498</ArticleId><ArticleId IdType="pubmed">29354059</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma H. Statistical significance or clinical significance? A researcher&#x2019;s dilemma for appropriate interpretation of research results. Saudi J Anaesth 2021; 15(4): 431&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8477766</ArticleId><ArticleId IdType="pubmed">34658732</ArticleId></ArticleIdList></Reference><Reference><Citation>Oosting SF, Barriuso J, Bottomley A, et al.. Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit. Ann Oncol 2023; 34(4): 431&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pubmed">36549587</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntosh SA, Alam F, Adams L, et al.. Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments. Lancet Oncol 2023; 24(6): 636&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pubmed">37269844</ArticleId></ArticleIdList></Reference><Reference><Citation>Pramesh CS, Badwe RA, Bhoo-Pathy N, et al.. Priorities for cancer research in low- and middle-income countries: a global perspective. Nat Med 2022; 28(4): 649&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9108683</ArticleId><ArticleId IdType="pubmed">35440716</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercier KA, Walsh DM. The initiation, design, and establishment of the Desmoid Tumor Research Foundation Patient Registry and Natural History Study. Rare Tumors 2019; 11: 203636131988097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792280</ArticleId><ArticleId IdType="pubmed">31662832</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrossi S. Cancer registration and information systems in Latin America. Lancet Oncol 2015; 16(14): 1400&#x2013;1401.</Citation><ArticleIdList><ArticleId IdType="pubmed">26522154</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi&#xf1;eros M, Abriata MG, Mery L, et al.. Cancer registration for cancer control in Latin America: a status and progress report. Rev Panam Salud Publica 2017; 41: e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6660887</ArticleId><ArticleId IdType="pubmed">31391813</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkowiak D, Domaradzki J. Are rare diseases overlooked by medical education? Awareness of rare diseases among physicians in Poland: an explanatory study. Orphanet J Rare Dis 2021; 16(1): 100808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8479904</ArticleId><ArticleId IdType="pubmed">34583737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramalle-G&#xf3;mara E, Dom&#xed;nguez-Garrido E, G&#xf3;mez-Egu&#xed;laz M, et al.. Education and information needs for physicians about rare diseases in Spain. Orphanet J Rare Dis 2020; 15(1): 18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6969468</ArticleId><ArticleId IdType="pubmed">31952528</ArticleId></ArticleIdList></Reference><Reference><Citation>Boffin N, Swinnen E, Wens J, et al.. General practice care for patients with rare diseases in Belgium. A cross-sectional survey. Int J Environ Res Public Health 2018; 15(6): 1180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6025074</ArticleId><ArticleId IdType="pubmed">29874870</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott EJ, Zurynski YA. Rare diseases are a &#x201c;common&#x201d; problem for clinicians. Aust Fam Physician 2015; 44(9): 630&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">26488039</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas A, Braggio D, Hernandez L, et al.. A retrospective collection of diagnostic data from the desmoid tumor research foundation natural history study. J Clin Oncol 2021; 39: 15(Suppl): e23549&#x2013;e23549.</Citation></Reference><Reference><Citation>Qamar JB, Uzair M, Ahmed S, et al.. The role of medical students in advocacy for rare diseases&#x2014;experience from a low- and middle-income country (LMIC). Rare 2023; 1: 100004.</Citation></Reference><Reference><Citation>Blay JY, Hindi N, Bollard J, et al.. SELNET clinical practice guidelines for soft tissue sarcoma and GIST. Cancer Treatment Rev 2022; 102: 102312.</Citation><ArticleIdList><ArticleId IdType="pubmed">34798363</ArticleId></ArticleIdList></Reference><Reference><Citation>Krist AH, Tong ST, Aycock RA, et al.. Engaging patients in decision-making and behavior change to promote prevention. Stud Health Technol Inform 2017; 240: 284&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6996004</ArticleId><ArticleId IdType="pubmed">28972524</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenheimer T. Patient self-management of chronic disease in primary care. JAMA 2002; 288(19): 2469.</Citation><ArticleIdList><ArticleId IdType="pubmed">12435261</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez MM, Bell T, Tumminello B, et al.. Disease and economic burden of surgery in desmoid tumors: a review. Expert Rev Pharmacoeconomics Outcomes Res 2023; 23(6): 607&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pubmed">37099290</ArticleId></ArticleIdList></Reference><Reference><Citation>Street RL, Makoul G, Arora NK, et al.. How does communication heal? Pathways linking clinician&#x2013;patient communication to health outcomes. Patient Educ Counsel 2009; 74(3): 295&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">19150199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper B, Str&#xf6;bel P, Hohenberger P. Desmoid tumors: clinical features and treatment options for advanced disease. Oncologist 2011; 16(5): 682&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3228186</ArticleId><ArticleId IdType="pubmed">21478276</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu A. Reflections: the value of patient support groups. Otolaryngol Head Neck Surg 2017; 156(4): 587&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pubmed">28366109</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzato O, Schuster K. The role of patient advocates and sarcoma community initiatives in musculoskeletal oncology. Moving towards evidence-based advocacy to empower evidence-based medicine. J Cancer Policy 2023; 36: 100413.</Citation><ArticleIdList><ArticleId IdType="pubmed">36806641</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper B, Schuster K, Wilson R, et al.. Global patient involvement in sarcoma care&#x2014;a collaborative initiative of the Connective Tissue Oncology Society (CTOS) &amp; Sarcoma Patients EuroNet (SPAEN). Cancers (Basel) 2022; 14(4): 854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8870105</ArticleId><ArticleId IdType="pubmed">35205602</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson R. The challenge of sarcomas: the patient advocacy group perspective. Clin Sarcoma Res 2019; 9: 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6636022</ArticleId><ArticleId IdType="pubmed">31346406</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross EE, Colbath RA, Yu J, et al.. Peer support groups: identifying disparities to improve participation. J Burn Care Res 2022; 43(5): 1019&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9435488</ArticleId><ArticleId IdType="pubmed">35781574</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38718322</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">0717-6384</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>08</Day></PubDate></JournalIssue><Title>Medwave</Title><ISOAbbreviation>Medwave</ISOAbbreviation></Journal><ArticleTitle>Protocol for a systematic mapping review of surgical and pharmacological interventions for the treatment of trigeminal neuralgia.</ArticleTitle><Pagination><StartPage>e2759</StartPage><MedlinePgn>e2759</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5867/medwave.2024.04.2759</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Trigeminal neuralgia is a painful neuropathic disorder characterized by sudden electric shock-like pain that significantly impacts patients' quality of life. Multiple treatment alternatives are available, including medical and surgical options but establishing the optimal course of action can be challenging. To enhance clinical decision-making for trigeminal neuralgia treatment, it is imperative to organize, describe and map the available systematic reviews and randomized trials. This will help identify the best treatment alternatives supported by evidence and acknowledge potential knowledge gaps where future research is needed.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This systematic mapping review aims to provide up-to-date evidence on the different surgical and pharmacological treatment alternatives used for trigeminal neuralgia.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A search will be systematically conducted on the Epistemonikos database to identify potentially eligible systematic reviews. Additionally, a search will be made in PubMed, CENTRAL, and EBSCO to identify randomized controlled trials assessing pharmacological and surgical treatment interventions for trigeminal neuralgia. Two independent reviewers will screen and select the studies. Data on the different treatment alternatives and reported outcomes in the included studies will be extracted using standardized forms. Following extraction, descriptive statistical methods will be used to analyze the data. The final output of this study will include an evidence map that will illustrate the connections between different treatments and their respective outcomes, providing a clear depiction of the evidence landscape.</AbstractText><AbstractText Label="EXPECTED RESULTS" NlmCategory="UNASSIGNED">This study expects to map, describe and assess the methodological quality of the available systematic reviews and trials on pharmacological interventions and neurosurgical procedures for treating trigeminal neuralgia. It will present the results in an evidence map that organizes the available evidence based on their different interventions and outcomes. This evidence map will serve as a visual tool to assist healthcare professionals and patients to understand evidence-based treatment options and their implications for managing this medical condition.</AbstractText><AbstractText Label="INTRODUCCI&#xd3;N" NlmCategory="UNASSIGNED">La neuralgia del trig&#xe9;mino es un trastorno neurop&#xe1;tico doloroso caracterizado por un dolor s&#xfa;bito y agudo, similar a una descarga el&#xe9;ctrica, que impacta significativamente en la calidad de vida. Dada la variedad de tratamientos disponibles, m&#xe9;dicos y quir&#xfa;rgicos, es crucial organizar y mapear la evidencia proveniente de revisiones sistem&#xe1;ticas y ensayos cl&#xed;nicos para orientar las decisiones cl&#xed;nicas. Esto permite identificar tratamientos respaldados por evidencia y se&#xf1;alar &#xe1;reas de investigaci&#xf3;n futura.</AbstractText><AbstractText Label="OBJETIVO" NlmCategory="UNASSIGNED">El prop&#xf3;sito de esta revisi&#xf3;n sistem&#xe1;tica de mapeo es proporcionar una visi&#xf3;n actualizada de la evidencia existente en relaci&#xf3;n con las diversas opciones de tratamiento quir&#xfa;rgico y farmacol&#xf3;gico empleadas en el manejo de la neuralgia del trig&#xe9;mino.</AbstractText><AbstractText Label="M&#xc9;TODOS" NlmCategory="UNASSIGNED">Se realizar&#xe1; una b&#xfa;squeda sistem&#xe1;tica en la base de datos Epistemonikos para identificar potenciales revisiones sistem&#xe1;ticas. Adicionalmente, se buscar&#xe1; en PubMed, CENTRAL y EBSCO ensayos cl&#xed;nicos aleatorizados que eval&#xfa;en intervenciones de tratamiento farmacol&#xf3;gico y quir&#xfa;rgico para la neuralgia del trig&#xe9;mino. Dos revisores independientes cribar&#xe1;n y seleccionar&#xe1;n los estudios. Se extraer&#xe1;n datos sobre las diferentes alternativas de tratamiento y los resultados reportados en los estudios incluidos utilizando formularios estandarizados. Tras la extracci&#xf3;n, se utilizar&#xe1;n m&#xe9;todos estad&#xed;sticos descriptivos para analizar los datos. El producto final de este estudio incluir&#xe1; un mapa de evidencia que ilustrar&#xe1; las conexiones entre los diferentes tratamientos y sus respectivos resultados, proporcionando una representaci&#xf3;n clara del panorama de la evidencia.</AbstractText><AbstractText Label="RESULTADOS ESPERADOS" NlmCategory="UNASSIGNED">Los resultados que se extraer&#xe1;n de este mapeo sistem&#xe1;tico incluyen identificar y describir las diferentes alternativas, tanto farmacol&#xf3;gicas como quir&#xfa;rgicas, que existen para el tratamiento de la neuralgia del trig&#xe9;mino. Adem&#xe1;s, se planea presentar un mapa de evidencia que se basar&#xe1; en los ensayos cl&#xed;nicos aleatorizados y revisiones sistem&#xe1;ticas, el cual mostrar&#xe1; la evidencia de manera organizada entre las diferentes intervenciones y sus desenlaces. Este mapa de evidencia servir&#xe1; como una herramienta visual que ayudar&#xe1; a los profesionales de la salud y los pacientes a comprender mejor las opciones de tratamiento respaldadas por la evidencia y sus consecuencias en el manejo de esta condici&#xf3;n m&#xe9;dica.</AbstractText><CopyrightInformation>This work is licensed under a Creative Commons Attribution 4.0 International License.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ladevig</LastName><ForeName>Dominga</ForeName><Initials>D</Initials><Identifier Source="ORCID">0009-0006-9408-6897</Identifier><AffiliationInfo><Affiliation>Escuela de Odontolog&#xed;a, Facultad de Medicina, Cl&#xed;nica Alemana Universidad del Desarrollo, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veloso</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-0840-788X</Identifier><AffiliationInfo><Affiliation>Escuela de Odontolog&#xed;a, Facultad de Medicina, Cl&#xed;nica Alemana Universidad del Desarrollo, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;vila-Oliver</LastName><ForeName>Camila</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5348-6284</Identifier><AffiliationInfo><Affiliation>Escuela de Odontolog&#xed;a, Facultad de Medicina, Cl&#xed;nica Alemana Universidad del Desarrollo, Santiago, Chile.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Chile</Country><MedlineTA>Medwave</MedlineTA><NlmUniqueID>101581949</NlmUniqueID><ISSNLinking>0717-6384</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014277" MajorTopicYN="Y">Trigeminal Neuralgia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078202" MajorTopicYN="Y">Systematic Reviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="N">Clinical Decision-Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mapping review</Keyword><Keyword MajorTopicYN="N">Trigeminal nerve</Keyword><Keyword MajorTopicYN="N">Trigeminal neuralgia</Keyword></KeywordList><CoiStatement>No conflicts of interest are declared. No patient and public involvement took place in the development or conduct of this protocol.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>18</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>18</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>16</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38718322</ArticleId><ArticleId IdType="doi">10.5867/medwave.2024.04.2759</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38537232</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2444-054X</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Cirugia y cirujanos</Title><ISOAbbreviation>Cir Cir</ISOAbbreviation></Journal><ArticleTitle>Variant ELMO1 rs1345365 is associated with pseudoperniosis in patients with COVID-19.</ArticleTitle><Pagination><StartPage>139</StartPage><EndPage>140</EndPage><MedlinePgn>139-140</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/CIRU.22000470</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cabrera-Pivaral</LastName><ForeName>Carlos E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Departamento de Salud P&#xfa;blica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Direcci&#xf3;n M&#xe9;dica ME Piel, Centro Dermatol&#xf3;gico, Guadalajara, Jalisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez-Garc&#xed;a</LastName><ForeName>Sergio A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Instituto de Nutrici&#xf3;n de la Universidad de la Sierra Sur, Sistema de Universidades Estatales de Oaxaca (SUNEO), Miahuatl&#xe1;n de Porfirio D&#xed;az, Oaxaca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orozco-S&#xe1;nchez</LastName><ForeName>Judan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Direcci&#xf3;n M&#xe9;dica ME Piel, Centro Dermatol&#xf3;gico, Guadalajara, Jalisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casta&#xf1;eda-Salazar</LastName><ForeName>V&#xed;ctor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Direcci&#xf3;n M&#xe9;dica ME Piel, Centro Dermatol&#xf3;gico, Guadalajara, Jalisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dom&#xed;nguez-Rodas</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n M&#xe9;dica Traslacional y de Medicina de Precisi&#xf3;n (CIMETP), Servicios M&#xe9;dicos Profesionales Particulares A.C., Miahuatl&#xe1;n de Porfirio D&#xed;az, Oaxaca. M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>La variante rs1345365 de ELMO1 est&#xe1; asociada a pseudoperniosis en pacientes con COVID-19.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Cir Cir</MedlineTA><NlmUniqueID>0372736</NlmUniqueID><ISSNLinking>0009-7411</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C465214">ELMO1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>17</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38537232</ArticleId><ArticleId IdType="doi">10.24875/CIRU.22000470</ArticleId><ArticleId IdType="pii">j92/1/139</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>